Literature DB >> 8967671

Human granulocytic ehrlichiosis: a case series from a medical center in New York State.

M E Aguero-Rosenfeld1, H W Horowitz, G P Wormser, D F McKenna, J Nowakowski, J Muñoz, J S Dumler.   

Abstract

BACKGROUND: Human granulocytic ehrlichiosis (HGE) is a newly described illness with few reports in the literature.
OBJECTIVE: To describe the clinical and laboratory feature of HGE.
DESIGN: Case series.
SETTING: Tertiary care facility in New York State. PATIENTS: 18 adult patients with HGE. MEASUREMENTS: Epidemiologic, clinical, and laboratory features; treatment; and outcome of patients with HGE.
RESULTS: Patients presented with such symptoms as fever (94%) and myalgia or arthralgia (78%). Thirteen patients (71%) recalled being bitten by a tick before onset of symptoms. Leukopenia or thrombocytopenia was seen in 82% of patients, and abnormal liver enzyme levels were seen in 81%. Results of polymerase chain reaction were positive in 9 of 12 patients (75%); morulae were seen in 3 of 12 patients (25%); and the agent that causes HGE was cultured from 2 patients. All but one patient (94%) developed antibodies to Ehrlichia equi. Five patients (28%) were briefly hospitalized, and none died. All patients were successfully treated with doxycycline.
CONCLUSIONS: The illness associated with HGE in these patients from the northeastern United States was more mild than that originally described in reports of HGE in the midwestern United States.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8967671     DOI: 10.7326/0003-4819-125-11-199612010-00006

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  55 in total

1.  Survival of the human granulocytic ehrlichiosis agent under refrigeration conditions.

Authors:  F Kalantarpour; I Chowdhury; G P Wormser; M E Aguero-Rosenfeld
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Serological responses to Ehrlichia equi, Ehrlichia chaffeensis, and Borrelia burgdorferi in patients from New York State.

Authors:  S J Wong; G S Brady; J S Dumler
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

3.  Serology of culture-confirmed cases of human granulocytic ehrlichiosis.

Authors:  M E Aguero-Rosenfeld; F Kalantarpour; M Baluch; H W Horowitz; D F McKenna; J T Raffalli; T c Hsieh; J Wu; J S Dumler; G P Wormser
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

4.  Equine and canine Anaplasma phagocytophilum strains isolated on the island of Sardinia (Italy) are phylogenetically related to pathogenic strains from the United States.

Authors:  Alberto Alberti; Rosanna Zobba; Bernardo Chessa; Maria Filippa Addis; Olivier Sparagano; Maria Luisa Pinna Parpaglia; Tiziana Cubeddu; Gianpaolo Pintori; Marco Pittau
Journal:  Appl Environ Microbiol       Date:  2005-10       Impact factor: 4.792

5.  Comparison of major antigenic proteins of six strains of the human granulocytic ehrlichiosis agent by Western immunoblot analysis.

Authors:  N Zhi; Y Rikihisa; H Y Kim; G P Wormser; H W Horowitz
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

6.  Efficacy of an OspA vaccine preparation for prevention of Lyme disease in New York State.

Authors:  G P Wormser; J Nowakowski; R B Nadelman; I Schwartz; D McKenna; D Holmgren; M Aguero-Rosenfeld
Journal:  Infection       Date:  1998 Jul-Aug       Impact factor: 3.553

7.  Serologic testing for human granulocytic ehrlichiosis at a national referral center.

Authors:  J A Comer; W L Nicholson; J G Olson; J E Childs
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

8.  Immunodiagnosis of human granulocytic ehrlichiosis by using culture-derived human isolates.

Authors:  M D Ravyn; J L Goodman; C B Kodner; D K Westad; L A Coleman; S M Engstrom; C M Nelson; R C Johnson
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

9.  Neutrophil NADPH oxidase is reduced at the Anaplasma phagocytophilum phagosome.

Authors:  Jacob W IJdo; Angel C Mueller
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

10.  Cloning and expression of the 44-kilodalton major outer membrane protein gene of the human granulocytic ehrlichiosis agent and application of the recombinant protein to serodiagnosis.

Authors:  N Zhi; N Ohashi; Y Rikihisa; H W Horowitz; G P Wormser; K Hechemy
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.